Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Clinical trial NCT01191892 · COMPLETED
Trial details
- NCT number
- NCT01191892
- Sponsor
- Cardiff University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.